MEDICINES CO's ticker is MDCO and the CUSIP is 584688105. A total of 263 filers reported holding MEDICINES CO in Q3 2019. The put-call ratio across all filers is 1.15 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $66,588,000 | +69.9% | 783,950 | 0.0% | 6.18% | +41.5% |
| Q3 2019 | $39,197,000 | +114.7% | 783,950 | +56.6% | 4.37% | +143.1% |
| Q2 2019 | $18,260,000 | +335.6% | 500,700 | +233.8% | 1.80% | +374.4% |
| Q1 2019 | $4,192,000 | -80.7% | 150,000 | -79.4% | 0.38% | -81.4% |
| Q3 2018 | $21,750,000 | -18.5% | 727,205 | 0.0% | 2.04% | -14.9% |
| Q2 2018 | $26,688,000 | +168.1% | 727,205 | +140.6% | 2.40% | +162.8% |
| Q1 2018 | $9,954,000 | +318.6% | 302,205 | +247.4% | 0.91% | +343.7% |
| Q4 2017 | $2,378,000 | -26.2% | 87,001 | 0.0% | 0.21% | -37.0% |
| Q3 2017 | $3,222,000 | -2.5% | 87,001 | 0.0% | 0.33% | -28.8% |
| Q2 2017 | $3,306,000 | – | 87,001 | – | 0.46% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sarissa Capital Management LP | 4,202,000 | $153,246,000 | 19.10% |
| Antipodean Advisors LLC | 257,000 | $9,373,000 | 11.40% |
| Aviva Holdings Ltd. | 982,831 | $35,844,000 | 7.50% |
| BRIDGER MANAGEMENT, LLC | 2,314,014 | $84,392,000 | 6.62% |
| Slate Path Capital LP | 3,545,000 | $129,286,000 | 5.80% |
| CVI Holdings, LLC | 338,850 | $12,357,000 | 4.78% |
| DLD Asset Management, LP | 2,917,800 | $106,412,000 | 4.43% |
| Camber Capital Management LP | 1,700,000 | $61,999,000 | 2.89% |
| Maven Securities LTD | 109,386 | $3,994,000 | 2.66% |
| Parian Global Management LP | 110,100 | $4,015,000 | 2.60% |